INTERNATIONAL PATENT: HEMANEXT INC. FILES APPLICATION FOR "TREATMENT OF BLOOD TRANSFUSION-DEPENDENT PATIENTS WITH HEMATOLOGIC MALIGNANCIES"

GENEVA, May 1 -- HEMANEXT INC. (99 Hayden AvenueBuilding B, Suite 620LEXINGTON, Massachusetts 02421) filed a patent application (PCT/US2023/077484) for "TREATMENT OF BLOOD TRANSFUSION-DEPENDENT PATIENTS WITH HEMATOLOGIC MALIGNANCIES" on Oct 20, 2023. With publication no. WO/2024/086835, the details related to the patent application was published on Apr 25, 2024.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CANNON, Martin (c/o HEMANEXT INC.99 Hayden AvenueBuilding B, Suite 620LEXINGTON, Massachusetts 02421), DUNHAM, Andrew (c/o HEMANEXT INC.99 Hayden AvenueBuilding B, Suite 620LEXINGTON, Massach...